Insider · CIK 0001986112
Erez Aminov
Files at MIRA (MIRA PHARMACEUTICALS, INC.), TELO (Telomir Pharmaceuticals, Inc.). First filing May 22, 2024, latest Nov 27, 2024.
In brief
Erez Aminov files SEC Form 4 as CEO, director and chair at MIRA (MIRA PHARMACEUTICALS, INC.), and also at TELO (Telomir Pharmaceuticals, Inc.). Since May 22, 2024, Erez Aminov has reported 1 open-market buy worth $8,176 and 1 open-market sell worth $134k, the latest filed on Nov 27, 2024.
A track record needs three past buys with six months of prices behind them; Erez Aminov has 0, so none is measured yet.
The newest scored trade: sold $134k of MIRA on Nov 19, 2024, filed Nov 27, 2024, scored 16 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIRA: MIRA PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | MIRA PHARMACEUTICALS, INC. | $134k 100,000 shares | -9% | - | |
| 33Weak | MIRAbuy MIRA PHARMACEUTICALS, INC. | $8,176 8,700 shares | +2% | +56% from low-86% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 19, 2024 | MIRA Mira Pharmaceuticals, Inc. | 100,000 0.60% of outstanding | $141k | Nov 19, 2024 | none |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | AGrant or award Incentive Stock Options (right to buy)derivative | +1,960,170 | - | - | 1,960,170 | May 22, 2026 |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | DDisposition to issuer Incentive Stock Options (right to buy)derivative | -1,960,170 | - | - | 0 | May 22, 2026 |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | AGrant or award Non-Qualified Stock Options (right to buy)derivative | +2,000,000 | - | - | 2,000,000 | May 22, 2026 |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | DDisposition to issuer Non-Qualified Stock Options (right to buy)derivative | -2,000,000 | - | - | 0 | May 22, 2026 |
| Apr 22, 2026 | TELO Telomir Pharmaceuticals, Inc. | JOther Common Stock | +7,319,710 | $1.37 | $10M | 7,319,710 | Apr 24, 2026 |
| Mar 30, 2026 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +83,500 | $0.00 | $0 | 83,500 | Apr 1, 2026 |
| Oct 1, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Common Stock | +2,685,456 | - | - | 3,530,156 | Oct 3, 2025 |
| Sep 18, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative10b5-1 | +150,000 | $0.00 | $0 | 150,000 | Sep 18, 2025 |
| Sep 18, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative10b5-1 | +150,000 | $0.00 | $0 | 150,000 | Sep 18, 2025 |
| Aug 29, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Common Stock | +62,500 | $1.37 | $86k | 844,700 | Sep 3, 2025 |
| May 28, 2025 | TELO Telomir Pharmaceuticals, Inc. | AGrant or award Non-Qualified Optionsderivative | +2,000,000 | $0.00 | $0 | 2,000,000 | May 30, 2025 |
| May 28, 2025 | TELO Telomir Pharmaceuticals, Inc. | AGrant or award Restricted Stock Units (RSUs)derivative | +400,000 | $0.00 | $0 | 400,000 | May 30, 2025 |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Stock Options (right to buy)derivative | +2,000,000 | $0.00 | $0 | 2,000,000 | Dec 10, 2024 |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +500,000 | $0.00 | $0 | 500,000 | Dec 10, 2024 |
| Nov 19, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -55,410 | $1.39 | $77k | 1,105,790 | Nov 27, 2024 |
| Nov 20, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -44,590 | $1.27 | $57k | 1,061,200 | Nov 27, 2024 |
| May 28, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Incentive Stock Options (right to buy)derivative | +379,000 | $0.00 | $0 | 629,000 | May 30, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +2,000 | $1.00 | $2,000 | 375,500 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +1,000 | $1.03 | $1,030 | 376,500 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +500 | $1.02 | $510 | 377,000 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +2,000 | $0.84 | $1,680 | 379,000 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +1,000 | $0.85 | $850 | 380,000 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +600 | $0.87 | $522 | 380,600 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +800 | $1.01 | $808 | 381,400 | May 22, 2024 |
| May 21, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +800 | $0.97 | $776 | 382,200 | May 22, 2024 |
| Mar 26, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | AGrant or award Incentive Stock Option (right to buy)derivative | +300,000 | $0.00 | $0 | 250,000 | Mar 27, 2024 |
Questions about Erez Aminov
Answered from the filings on this page, as of the latest one.
Is Erez Aminov buying or selling?
Not in the last 12 months. Erez Aminov's latest open-market trade on SEC Form 4 was sold $134k of MIRA on Nov 19, 2024.
How did Erez Aminov's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Erez Aminov has 0.
Where does Erez Aminov file Form 4?
Erez Aminov has filed Form 4 at MIRA (MIRA PHARMACEUTICALS, INC.) as Chief Executive Officer; TELO (Telomir Pharmaceuticals, Inc.) as CEO and Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.